Categories
Blood Cancer

Which Covid-19 booster is best for myeloma patients? [Video]

Which Covid-19 booster is best for myeloma patients?

Myeloma expert Dr. Brian G.M. Durie talks COVID-19 boosters and which is best for patients with multiple myeloma.

The BOTTOM LINE: Myeloma patients are recommended to get a booster shot. Talk to your doctor about the pros and cons of choosing the Moderna vaccine as a booster.
_______________
Improving Lives | Finding the Cure

In the United States, an estimated 32,270 new multiple myeloma cases will be diagnosed in 2021. 159,985 new myeloma cases are diagnosed yearly.

Founded in 1990, the International Myeloma Foundation (IMF) is the first and largest organization focusing specifically on multiple myeloma. The IMF’s reach extends to more than 525,000 members in 140 countries worldwide. The IMF is dedicated to improving the quality of lives of myeloma patients while working toward prevention and a cure through our four founding principles: Research, Education, Support, and Advocacy.

Subscribe to our channel: https://www.youtube.com/c/IMFMyeloma

Visit our website at: https://www.myeloma.org

Find us online:
Facebook: @myeloma | https://facebook.com/myeloma
Twitter: @IMFMyeloma | https://twitter.com/IMFmyeloma
Instagram: @imfmyeloma | https://www.instagram.com/imfmyeloma
LinkedIn: https://www.linkedin.com/company/international-myeloma-foundation

Support the IMF! http://bit.ly/WskQHC
Category
Nonprofits & Activism
License
Standard YouTube License

In most cases, captions are autogenerated by YouTube.

Watch/Read More
Categories
Blood Cancer

Whole tumor cell vaccination for treatment of mouse lymphoma [Video]

Modified whole EL-4 lymphoma cells were used as vaccines to treat EL-4 lymphoma. The vaccines induced specific T and B cell immune responses to cure the lymphoma. Elevated Anti-tumor IgG can be used for identification of targeted neoantigens and developing new immunotherapy.

Categories
Blood Cancer

BELINDA: Tisagenlecleucel in B-cell NHL [Video]

Michael Bishop, MD, University of Chicago, Chicago, IL, discusses results from the Phase III BELINDA trial (NCT03570892), which assessed tisagenlecleucel (tisa-cel), a chimeric antigen receptor (CAR) T-cell therapy, in patients with aggressive B-cell non-Hodgkin lymphoma. The primary endpoint, which was event-free survival, was not met, and tisa-cel was not superior to the current standard of care. Dr Bishop highlights the time taken for the therapy to be administered, bridging therapy, and the dosage of lymphodepleting chemotherapy to be factors affecting the trial results. This interview took place at the 63rd ASH Annual Meeting and Exposition congress in Atlanta, GA.

Categories
Blood Cancer

House on the Rock Church | Healing Testimony: Carole - Blood Cancer [Video]

Carole R. shares how getting serious about her relationship with God moved her from multiple years of health issues and a cancer diagnosis to being almost fully healed of her sicknesses. Listen as Carole tells more in-depth about her faith growing in the midst of God healing her.A CHURCH WHERE YOU CAN BELONGWhether you’re a seasoned church veteran, are shopping around for a new place to call home or are questioning what it looks like to have faith in Jesus Christ, we want to walk with you on your faith journey. At House on the Rock Church we see ourselves not as a church building with members but as bridge builders with a unique opportunity to share the love of Christ to a hurting and broken world. Our heart is to dive into the community and show this love in a way that’s culturally relevant in our ever-changing society. Our diverse church community is full of families both big and small. Whether you’re new to following Jesus or have been walking with him all your life, we are ready to welcome you with loving and open arms. It would be a great honor and joy to worship and live this life with you.Get in Touch6560 Merritt Rd • Ypsilanti, MI 48197734.433.6080https://hotrockchurch.org/#healing #healingtestimony #testimony